Vol 9 Issue 8

CELL AND GENE THERAPY INSIGHTS

September 2023 Issue

Vol 9 Issue 8

Download PDF

Featuring

Issue Spotlight: Scale-up/-out of cell & gene therapy manufacturing
Other articles
Webinars

SPOTLIGHT

Scale-up/-out of cell & gene therapy manufacturing
John Moscariello
Guest Editor:
John Moscariello, Vice President, Cell Therapy Drug Product Process Development at Bristol Myers Squibb

Innovator Insight

An automated, closed system for rapid manufacturing of engineered T cells

An automated, closed system for rapid manufacturing of engineered T cells

Sophia Lollies, Ian Johnston
19 October 2023
Read

Interview

Overcoming the challenge of antiviral defense in viral vector manufacturing

Overcoming the challenge of antiviral defense in viral vector manufacturing

Jean-Simon Diallo , Jondavid De Jong
21 September 2023
Read
Considerations around the scalability of automated cell therapy manufacturing

Considerations around the scalability of automated cell therapy manufacturing

Krishnendu Roy
27 July 2023
Read

Podcast

Happy medium: considerations in scaling cell culture media strategies

Happy medium: considerations in scaling cell culture media strategies

Dalip Sethi
17 August 2023
Listen

FastFacts

How to achieve both cost and quality goals in plasmid manufacturing

How to achieve both cost and quality goals in plasmid manufacturing

Silvia Orsini
22 September 2023
Read
Quality by design planning in ATMPs: standards for manufacturers

Quality by design planning in ATMPs: standards for manufacturers

Matthew Chorley
22 September 2023
Read

Viewpoint

Scale-up and automation of iPSC-derived cell therapy manufacturing

Scale-up and automation of iPSC-derived cell therapy manufacturing

Dhruv Sareen, Jonathan Rodriguez, Hojae Lee
5 October 2023
Read

Journal articles

Innovator Insight

Regulatory considerations & validation strategies for mycoplasma testing for cell-based therapies

Regulatory considerations & validation strategies for mycoplasma testing for cell-based therapies

Michael Brewer
14 September 2023
Read
How reducing labor time can save on your cell therapy manufacturing costs

How reducing labor time can save on your cell therapy manufacturing costs

Yen Kong, Jeeheon Kang, Janôt Schoep
13 September 2023
Read
Utilizing an automation-on-demand analytical tool for cancer immunotherapy

Utilizing an automation-on-demand analytical tool for cancer immunotherapy

Christoph Eberle
22 September 2023
Read
High-throughput process & analytical platforms to accelerate gene therapy scale-up

High-throughput process & analytical platforms to accelerate gene therapy scale-up

Patrick Starremans, Kenneth Warrington, Nithya Jesuraj
28 September 2023
Read
Early-stage considerations for accelerating cell and gene therapy commercialization

Early-stage considerations for accelerating cell and gene therapy commercialization

Sabrina Carmichael
29 September 2023
Read

FastFacts

Analyzing lentivirus particles using dPCR techniques

Analyzing lentivirus particles using dPCR techniques

Samyuktha Shankar
21 September 2023
Read

Viewpoint

How to expedite clinical development of oncology agents: overcoming complexities of early-phase oncology trials for ATMPs

How to expedite clinical development of oncology agents: overcoming complexities of early-phase oncology trials for ATMPs

Harriet Gray Stephens
29 September 2023
Read

Webinar Digest

Improving biopharmaceutical quality and safety by implementing a microbial identification strategy in the workflow

Improving biopharmaceutical quality and safety by implementing a microbial identification strategy in the workflow

Nico Chow
14 September 2023
Read

Webinars